LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma, today announced that its management is scheduled to present at the 34th Annual J.P. Morgan Healthcare Conference at The Westin St. Francis in San Francisco on Tuesday, January 12, 2016, at 2:30 p.m. PST. A live webcast of the presentation will be available in the Investors section of the Glaukos website at http://investors.glaukos.com.
